These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33749403)

  • 1. Association between hyperlipidemia and prostatic enlargement: A case-control study.
    Erbay G; Ceyhun G
    Urologia; 2022 Feb; 89(1):58-63. PubMed ID: 33749403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of causes of failure of medical treatment in patients undergoing surgery for benign prostate enlargement.
    Anand A; Gupta NP; Dogra PN; Seth A
    Urologia; 2022 Nov; 89(4):553-558. PubMed ID: 34965812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
    De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
    Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
    Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
    Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with depressive symptoms in patients with benign prostatic enlargement.
    Abdalla HH; Shah J; Nyanja TAN; Shabani JS
    Afr J Prim Health Care Fam Med; 2023 May; 15(1):e1-e7. PubMed ID: 37265158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.
    Presicce F; De Nunzio C; Tubaro A
    Curr Urol Rep; 2018 Jul; 19(9):70. PubMed ID: 29987480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
    Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
    Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
    Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
    Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Investigation of Relationship between Coronary Artery Ectasia, Benign Prostatic Enlargement, and Lower Urinary Tract Symptoms.
    İnci M; Baydilli N; Akçay AB; Demirtaş A; Rifaioğlu MM; Gözükara KH; Kaya MG
    Urology; 2015 Jun; 85(6):1436-40. PubMed ID: 25865115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study.
    Besiroglu H; Ozbek E; Dursun M; Otunctemur A
    Aging Male; 2018 Mar; 21(1):40-47. PubMed ID: 28823197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms.
    Corona G; Salvi M; Sebastianelli A; Bossa R; Vignozzi L; Maggi M; De Nunzio C; Serni S; Gratzke C; Gravas S; Gacci M
    Minerva Urol Nefrol; 2020 Apr; 72(2):135-143. PubMed ID: 31920062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
    Feng T; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Int J Urol; 2017 Feb; 24(2):151-156. PubMed ID: 28004415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
    Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
    Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.